Price
Target price
€61.10
€61.10
0.360%
0.22
0.360%
€93.73
04.07.25 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
The Corcept Therapeutics Inc. stock is trending slightly upwards today, with an increase of €0.22 (0.360%) compared to yesterday's price.
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Corcept Therapeutics Inc..
With a target price of 93 € there is a hugely positive potential of 52.21% for Corcept Therapeutics Inc. compared to the current price of 61.1 €.
Our community identified positive and negative aspects for Corcept Therapeutics Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Corcept Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | 0.360% | -2.365% | -0.326% | 114.989% | 22.666% | 150.410% | 307.333% |
| Rockwell Medical Inc. | -0.150% | 1.711% | -21.930% | -57.201% | -66.096% | -43.042% | -96.323% |
| Pacira Pharmaceuticals | 0.000% | -2.030% | -15.351% | -2.030% | 4.324% | -64.259% | -58.043% |
| Twist Bioscience Corp | -0.310% | 4.886% | 20.735% | -26.366% | -29.587% | -9.193% | -21.845% |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at HC Wainwright from $150.00 to $145.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $128.00 to $131.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $76.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
News
3 Biopharmaceutical Stocks Bucking the Sell-Off
With tariffs sending markets reeling in the first days of the second quarter—the S&P 500 dropped roughly 10% in the five trading periods through Apr. 7, 2025—investors with cash to spend might be
Corcept Therapeutics Stock: Record High Fuels Analyst Optimism
Corcept Therapeutics has achieved a remarkable milestone as its stock price soared to an all-time high of $71.30, propelling the company's market capitalization to an impressive $7.4 billion. This
